Evidence map›Paper›PMID 33966639›Full record

ReviewJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2021

Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR).

Karen G Ordovas, Lauren A Baldassarre, Chiara Bucciarelli-Ducci, James Carr, Juliano Lara Fernandes, Vanessa M Ferreira, Luba Frank, Sophie Mavrogeni, Ntobeko Ntusi, Ellen Ostenfeld and 8 more

Abstract readReviewConsensus Statement
In one paragraph

Review in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Competency based curriculum for cardiovascular magnetic resonance: A position statement of the Society for Cardiovascular Magnetic Resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2024
    Guideline
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Pregnancy-Related Cardiovascular Diseases: A Radiological Overview.Journal of cardiovascular development and disease · 2025
    Review
  8. Impactful Cardiac CT and MRI Articles from 2023.Radiology. Cardiothoracic imaging · 2024
    Review
  9. Article
  10. Review
  11. Medical Radiology: Current Progress.Diagnostics (Basel, Switzerland) · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. 2021-2022 state of our JCMR.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2022
    Review
  16. Imaging of heart disease in women: review and case presentation.European journal of nuclear medicine and molecular imaging · 2022
    Review
  17. Position Statement on Women's Cardiovascular Health - 2022.Arquivos brasileiros de cardiologia · 2022
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Karen G OrdovasUniversity of Washington, Seattle, USA. ordovask@uw.edu.ORCID 0000-0001-5438-4669
Lauren A BaldassarreYale University, New Haven, CT, USA.
Chiara Bucciarelli-DucciBristol Heart Institute, Bristol, UK.
James CarrDepartment of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Juliano Lara FernandesJose Michel Kalaf Research Institute, Radiologia Clinica de Campinas, São Paulo, Brazil.
Vanessa M FerreiraOxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Luba FrankMedical College of Wisconsin, Wisconsin, USA.
Sophie MavrogeniOnassis Cardiac Surgery Center, Athens, Greece.
Ntobeko NtusiUniversity of Cape Town, Cape Town, South Africa.
Ellen OstenfeldDepartment of Clinical Sciences Lund, Clinical Physiology, Skåne University Hospital Lund, Lund University, Lund, Sweden.
Purvi ParwaniDivision of Cardiology, Department of Medicine, Loma Linda University Health, Loma Linda, CA, USA.
Alessia PepeMagnetic Resonance Imaging Unit, Fondazione G. Monasterio C.N.R., Pisa, Italy.
Subha V RamanKrannert Institute of Cardiology, Indiana University, Indianapolis, USA.
Hajime SakumaDepartment of Radiology, Mie University School of Medicine, Mie, Japan.
Jeanette Schulz-Mengerharite Hospital, University of Berlin, Berlin, Germany.
Lilia M Sierra-GalanAmerican British Cowdray Medical Center, Mexico City, Mexico.
Anne Marie ValenteBoston Children's Hospital, Brigham and Women's Hospital, Boston, USA.
Monvadi B SrichaiGeorgetown University School of Medicine, Washington, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

This document is a position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) on recommendations for clinical utilization of cardiovascular magnetic resonance (CMR) in women with cardiovascular disease. The document was prepared by the SCMR Consensus Group on CMR Imaging for Female Patients with Cardiovascular Disease and endorsed by the SCMR Publications Committee and SCMR Executive Committee. The goals of this document are to (1) guide the informed selection of cardiovascular imaging methods, (2) inform clinical decision-making, (3) educate stakeholders on the advantages of CMR in specific clinical scenarios, and (4) empower patients with clinical evidence to participate in their clinical care. The statements of clinical utility presented in the current document pertain to the following clinical scenarios: acute coronary syndrome, stable ischemic heart disease, peripartum cardiomyopathy, cancer therapy-related cardiac dysfunction, aortic syndrome and congenital heart disease in pregnancy, bicuspid aortic valve and aortopathies, systemic rheumatic diseases and collagen vascular disorders, and cardiomyopathy-causing mutations. The authors cite published evidence when available and provide expert consensus otherwise. Most of the evidence available pertains to translational studies involving subjects of both sexes. However, the authors have prioritized review of data obtained from female patients, and direct comparison of CMR between women and men. This position statement does not consider CMR accessibility or availability of local expertise, but instead highlights the optimal utilization of CMR in women with known or suspected cardiovascular disease. Finally, the ultimate goal of this position statement is to improve the health of female patients with cardiovascular disease by providing specific recommendations on the use of CMR.

Indexed as

Cardiovascular DiseasesHeart Defects, CongenitalFemaleHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMalePredictive Value of TestsCardiovascular diseaseCardiovascular magnetic resonancePosition statementSociety for Cardiovascular Magnetic ResonanceWomen

Identifiers

PMID33966639
PMCPMC8108343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.